{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:30:56Z","timestamp":1790652656706,"version":"4.1.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"70","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,12,29]]},"DOI":"10.18632\/oncotarget.23258","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T13:16:10Z","timestamp":1513343770000},"page":"115315-115325","source":"Crossref","is-referenced-by-count":48,"title":["Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion"],"prefix":"10.18632","volume":"8","author":[{"given":"Kyungjin","family":"Lee","sequence":"first","affiliation":[{"name":"Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Eun","family":"Kim","sequence":"additional","affiliation":[{"name":"Anticancer Agent Research Center, Korea Research Institute of Bioscience & Biotechnology, Cheongju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Soon","family":"Jang","sequence":"additional","affiliation":[{"name":"Biomedical Omics Group, Korea Basic Science Institute, Cheongju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungchan","family":"Cho","sequence":"additional","affiliation":[{"name":"Anticancer Agent Research Center, Korea Research Institute of Bioscience & Biotechnology, Cheongju, South Korea"},{"name":"Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science and Technology, Daejeon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonsaeng","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, South Korea"},{"name":"Department of Medicinal and Pharmaceutical Chemistry, Korea University of Science and Technology, Daejeon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/spid.2002.29756","article-title":"Enterovirus infections: diagnosis and treatment","volume":"13","author":"Sawyer","year":"2002","journal-title":"Semin Pediatr Infect Dis"},{"key":"2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nrmicro1284","article-title":"Host and virus determinants of picornavirus pathogenesis and tropism","volume":"3","author":"Feuer","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01317504","article-title":"Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria","volume":"60","author":"Ninov","year":"1979","journal-title":"Arch Virol"},{"key":"4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4062\/biomolther.2013.108","article-title":"Antiviral activity of hederasaponin B from hedera helix against Enterovirus 71 Subgenotypes C3 and C4a","volume":"22","author":"Ko","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"key":"6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1165\/rcmb.2010-0288OC","article-title":"Pharmacologic activation of the innate immune system to prevent respiratory viral infections","volume":"45","author":"Kreindler","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1189\/jlb.0410216","article-title":"The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo","volume":"89","author":"Vogel","year":"2011","journal-title":"J Leukoc Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"e42583","DOI":"10.1371\/journal.pone.0042583","article-title":"RO 90-7501 enhances TLR3 and RLR agonist induced antiviral response","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.coviro.2012.08.009","article-title":"Regulators of innate immunity as novel targets for panviral therapeutics","volume":"2","author":"Lamarre","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1128\/AAC.02700-15","article-title":"Cross talk between nucleotide synthesis pathways with cellular immunity in constraining hepatitis E virus replication","volume":"60","author":"Pan","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"11","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1128\/AAC.00282-16","article-title":"Discovery of a broad-spectrum antiviral compound that inhibits pyrimidine biosynthesis and establishes a type 1 interferon-independent antiviral state","volume":"60","author":"Yin","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"12","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/hep.24202","article-title":"Ribavirin enhances interferon-stimulated gene transcription by activation of the interferon-stimulated response element","volume":"53","author":"van der Laan","year":"2011","journal-title":"Hepatology"},{"key":"13","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/hep.25562","article-title":"Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo","volume":"55","author":"van der Laan","year":"2012","journal-title":"Hepatology"},{"key":"14","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1128\/AAC.04779-14","article-title":"Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors","volume":"59","author":"Shi","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2015.10.011","article-title":"Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses","volume":"124","author":"Lee","year":"2015","journal-title":"Antiviral Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"e30286","DOI":"10.1371\/journal.pone.0030286","article-title":"Cellular growth kinetics distinguish a cyclophilin inhibitor from an HSP90 inhibitor as a selective inhibitor of hepatitis C virus","volume":"7","author":"Greenstein","year":"2012","journal-title":"PLoS One"},{"key":"17","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1128\/AAC.06161-11","article-title":"Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1","volume":"56","author":"Mansky","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"18","doi-asserted-by":"publisher","first-page":"35324","DOI":"10.1074\/jbc.M112.392142","article-title":"Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection","volume":"287","author":"Kantele","year":"2012","journal-title":"J Biol Chem"},{"key":"19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1021\/acsinfecdis.6b00116","article-title":"Cell-based high-throughput screening assay identifies 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine gemcitabine as a potential antipoliovirus agent","volume":"3","author":"Chen","year":"2017","journal-title":"ACS Infect Dis"},{"key":"20","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of middle east respiratory syndrome coronavirus infection","volume":"58","author":"Glass","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","volume":"139","author":"Vapalahti","year":"2017","journal-title":"Antiviral Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001813-199512006-00002","article-title":"Preclinical characteristics of gemcitabine","volume":"6","author":"Gandhi","year":"1995","journal-title":"Anticancer Drugs"},{"key":"23","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1128\/JVI.69.12.7782-7790.1995","article-title":"Genetic analysis of a hydrophobic domain of coxsackie B3 virus protein 2B: a moderate degree of hydrophobicity is required for a cis-acting function in viral RNA synthesis","volume":"69","author":"Melchers","year":"1995","journal-title":"J Virol"},{"key":"24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1099\/vir.0.81297-0","article-title":"Structural and functional characterization of the coxsackievirus B3 CRE(2C): role of CRE(2C) in negative- and positive-strand RNA synthesis","volume":"87","author":"Melchers","year":"2006","journal-title":"J Gen Virol"},{"key":"25","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"Goh","year":"2011","journal-title":"J Virol"},{"key":"26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Rice","year":"2011","journal-title":"Curr Opin Virol"},{"key":"27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Neyts","year":"2005","journal-title":"J Virol"},{"key":"29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/AAC.01795-13","article-title":"Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon","volume":"58","author":"Neyts","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"30","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1016\/S0021-9258(19)74507-4","article-title":"Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis","volume":"268","author":"De Clercq","year":"1993","journal-title":"J Biol Chem"},{"key":"31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/jir.2010.0101","article-title":"The ISG56\/IFIT1 gene family","volume":"31","author":"Sen","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ni.2048","article-title":"IFIT1 is an antiviral protein that recognizes 5\u2032-triphosphate RNA","volume":"12","author":"Colinge","year":"2011","journal-title":"Nat Immunol"},{"key":"33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.virusres.2008.06.004","article-title":"Structure and function of HCV IRES domains","volume":"139","author":"Lukavsky","year":"2009","journal-title":"Virus Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1128\/JVI.77.7.3898-3912.2003","article-title":"Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication","volume":"77","author":"Gale","year":"2003","journal-title":"J Virol"},{"key":"35","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1038\/emboj.2008.241","article-title":"Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1","volume":"27","author":"Sen","year":"2008","journal-title":"EMBO J"},{"key":"36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/jir.2010.0057","article-title":"Retinoic acid-inducible gene-I-like receptors","volume":"31","author":"Fujita","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5\u2032-phosphates","volume":"314","author":"Reis e Sousa","year":"2006","journal-title":"Science"},{"key":"38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Fujita","year":"2004","journal-title":"Nat Immunol"},{"key":"39","first-page":"19","article-title":"Induction of apoptosis by gemcitabine","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12985-016-0557-8","article-title":"Antiviral activity of micafungin against enterovirus 71","volume":"13","author":"Kim","year":"2016","journal-title":"Virol J"},{"key":"41","doi-asserted-by":"publisher","first-page":"e1005693","DOI":"10.1371\/journal.ppat.1005693","article-title":"Hepatitis B virus-induced parkin-dependent recruitment of linear ubiquitin assembly complex (LUBAC) to mitochondria and attenuation of innate immunity","volume":"12","author":"Siddiqui","year":"2016","journal-title":"PLoS Pathog"},{"key":"42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.antiviral.2016.07.024","article-title":"Antiviral activity of KR-23502 targeting nuclear export of influenza B virus ribonucleoproteins","volume":"134","author":"Kim","year":"2016","journal-title":"Antiviral Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"e0181076","DOI":"10.1371\/journal.pone.0181076","article-title":"Inactivation of human DGAT2 by oxidative stress on cysteine residues","volume":"12","author":"Cho","year":"2017","journal-title":"PLoS One"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T17:17:18Z","timestamp":1660151838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":43,"journal-issue":{"issue":"70","published-print":{"date-parts":[[2017,12,29]]}},"alternative-id":["23258","29383162"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23258","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}